ESC 365 - Doctor Ward Heggermont

Speaker illustration

Doctor Ward Heggermont

Cardiovascular Research Center Aalst, Aalst (Belgium)

Member of:

Ward Heggermont obtained his Medical Degree in 2009 at the Catholic University of Leuven (Belgium). After one year of clinical internship, he started his PhD thesis, sponsored by an FWO grant (Fonds Wetenschappelijk Onderzoek Vlaanderen (Belgium)), in October 2010, and succesfully obtained his PhD in 2016. He worked as a student-researcher in the Rega Institute (Leuven, Belgium), between 2004 and 2007. He has a particular interest in the overlapping scientific fields of Virology and Cardiology, and Metabolism. He worked on micro-RNAs involved in viral myocarditis, cardiac hypertrophy and heart failure. After a fellowship in Lugano (Prof. Dr. Angelo Auricchio) he now works as Full Staff Member at the Cardiovascular Center OLV Aalst, Belgium, and CARIM Maastricht, The Netherlands, with main interest in heart failure, cardiac resynchronization therapy, and cardio-oncology. He holds a degree in Specialized Medicine (MMed) and in Hospital Management (MSc).

Presentations Articles

Prediction of HF events based on remote monitoring.

Event: EHRA 2022

Topic: Clinical

Session: Atrial fibrillation (AF) and heart failure (HF) in the digital era

Roudtable discussion.

Event: ESC Congress 2021 - The Digital Experience

Topic: Arrhythmias, General

Session: Detect, triage and treat atrial fibrillation and heart failure

Managing heart failure patients with digital solutions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Arrhythmias, General

Session: Detect, triage and treat atrial fibrillation and heart failure

Constrictive Pericarditis vs. Restrictive Cardiomyopathy: you don’t need to roll the dice.

Event: ESC Congress 2018

Topic: Training and Education

Session: General cardiology crash course - part 1

The MiR-221/-222 cluster is elevated both in biopsies of patients with myocarditis and idiopathic non-ischemic cardiomyopathy but fails to discriminate between both pathologies

Event: Heart Failure 2018

Topic: Pathophysiology, Other

Session: Basic Science

MiR-126 is involved in allograft vasculopathy

Event: Heart Failure 2018

Topic: Chronic Ischaemia

Session: Basic Science

Serial endomyocardial microRNA-126 measurements in heart transplant recipients with and without allograft vasculopathy.

Event: ESC Congress 2016

Topic: Medical aspects of transplantation

Session: Young Investigators Awards Session Coronary Pathophysiology and Microcirculation

The microRNA-146a - DLST axis: a new therapeutic target in heart failure.

Event: HEART FAILURE 2016

Topic: Molecular biology / genetics

Session: Young Investigator Award: Basic and Translational Science

ESC 365 is supported by